Martin Diggle

Portfolio Manager, Life Sciences

Martin, who is a director and the fund manager of the Vulpes Life Sciences fund has been a passionate and active investor, with over 20 years of experience in life sciences.

He has served on the Board of several public and privately listed companies within our portfolio, including Oxford Biomedica, Scancell, Proteome Sciences, Chronos, Leucid and Oxford Endovascular.

Over the years he has been a huge advocate and supporter of life sciences where he has contributed both his own capital and extensive business experience to ensure that these companies reach their full potential.

Prior to Vulpes Martin was a Partner and Director of UBS/Brunswick. Before that, he spent 7 years at Morgan Stanley. Martin graduated from the University of Oxford with a Masters in Philosophy, Politics and Economics.